Skip to main content

Advertisement

SpringerLink
Log in

Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma

  • Original articles
  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Background Purpose

Although carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are the most studied serum tumor markers that have been evaluated for diagnosis and prognosis in patients with pancreatic cancer, little is known of the value of these markers for the prediction of curability and resectability.

Methods

We retrospectively reviewed preoperative serum levels of CEA and CA 19-9 in 244 consecutive patients with pancreatic operations.

Results

Although 159 pancreatic operations seemed “resectable”, 93 of them were judged curative (R0) and the other 66 turned out to be noncurative (R1/2). The remaining 85 failed resection because of unexpected metastasis or locally advanced disease (LD), which was unresectable compared with levels in those patients without liver metastasis or LD. CEA levels were significantly higher in patients with liver metastasis and LD, while CA 19-9 levels were correlated with liver and peritoneal metastases. When both markers were negative, curative (R0) and respectable (R0 + R1/2) operation were performed in 70% and 85% of patients, respectively. Logistic regression analysis indicated that under conditions where both CEA and CA 19-9 were negative, the odds ratios for curative and respectable operations were 4.43 and 3.58, respectively.

Conclusions

Our data suggest that combined preoperative CEA and CA 19-9 levels are suitable for assessing expected curability and resectability in patients with pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SF Sener A Fremgen HR Menck DP Winchester (1999) ArticleTitlePancreatic cancer: a report of treatment and survival trends for 100 313 patients diagnosed from 1985–1995, using the National Cancer Database J Am Coll Surg 189 1–7 Occurrence Handle10401733 Occurrence Handle10.1016/S1072-7515(99)00075-7 Occurrence Handle1:STN:280:DyaK1MzivVWlsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. L Blaszkowsky (1998) ArticleTitleTreatment of advanced and metastatic pancreatic cancer Front Biosci 3 214–25

    Google Scholar 

  3. S Egawa K Takeda S Fukuyama F Motoi M Sunamura S Matsuno (2004) ArticleTitleClinicopathological aspects of small pancreatic cancer Pancreas 28 235–40 Occurrence Handle15084963 Occurrence Handle10.1097/00006676-200404000-00004

    Article  PubMed  Google Scholar 

  4. HG Beger F Gansauge G Leder (2002) ArticleTitlePancreatic cancer: who benefits from curative resection? Can J Gastroenterol 16 117–20 Occurrence Handle11875596

    PubMed  Google Scholar 

  5. C Pasquali C Sperti C Filipponi S Pedrazzoli (2002) ArticleTitleEpidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival (1990–1992) Dig Liver Dis 34 723–31 Occurrence Handle12469800 Occurrence Handle10.1016/S1590-8658(02)80024-X Occurrence Handle1:STN:280:DC%2BD38jgslyhtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  6. B Kedra T Popiela M Sierzega A Precht (2001) ArticleTitlePrognostic factors of long-term survival after resective procedures for pancreatic cancer Hepatogastroenterology 48 1762–6 Occurrence Handle11813619 Occurrence Handle1:STN:280:DC%2BD38%2Fos1egtw%3D%3D

    PubMed  CAS  Google Scholar 

  7. G Benassai M Mastrorilli G Quarto A Cappiello U Giani P Forestieri F Mazzeo (2000) ArticleTitleFactors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas J Surg Oncol 73 212–8 Occurrence Handle10797334 Occurrence Handle10.1002/(SICI)1096-9098(200004)73:4<212::AID-JSO5>3.0.CO;2-D Occurrence Handle1:STN:280:DC%2BD3c3lvF2hsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  8. JP Neoptolemos DD Stocken JA Dunn J Almond HG Beger P Pederzoli et al. (2001) ArticleTitleInfluence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 234 758–68 Occurrence Handle11729382 Occurrence Handle10.1097/00000658-200112000-00007 Occurrence Handle1:STN:280:DC%2BD38%2FlvFSqsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  9. A Okamoto K Tsuruta K Karasawa N Miyanari G Matsumoto T Kamisawa N Egawa (2003) ArticleTitleResection versus palliation: treatment of stage III and IVA carcinomas of the pancreas employing intraoperative radiation World J Surg 27 599–605 Occurrence Handle12715231 Occurrence Handle10.1007/s00268-003-6579-6

    Article  PubMed  Google Scholar 

  10. J Baulieux JR Delpero (2000) ArticleTitleSurgical treatment of pancreatic cancer: curative resections Ann Chir 125 609–17 Occurrence Handle11051689 Occurrence Handle10.1016/S0003-3944(00)00251-0 Occurrence Handle1:STN:280:DC%2BD3crgsVWksQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  11. S Pedrazzoli C Sperti C Pasquali (1994) ArticleTitlePrediction of resectability and of surgical risk in pancreatic carcinoma; conditioning factors of survival after resective intervention Chir Ital 46 30–8 Occurrence Handle7954982 Occurrence Handle1:STN:280:DyaK2M%2Fkt12ntQ%3D%3D

    PubMed  CAS  Google Scholar 

  12. P Piantino A Andriulli T Gindro F Pecchio G Masoero G Cavallini et al. (1996) ArticleTitleCA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases Am J. Gastroenterol 81 436–9

    Google Scholar 

  13. F Safi W Schlosser G Kolb HG Beger (1997) ArticleTitleDiagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms J Gastrointest Surg 1 106–12 Occurrence Handle9834336 Occurrence Handle10.1016/S1091-255X(97)80097-2 Occurrence Handle1:STN:280:DC%2BD28nhslSguw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  14. MG Schlieman HS Ho RJ Bold (2003) ArticleTitleUtility of tumor markers in determining resectability of pancreatic cancer Arch. Surg 138 951–5 Occurrence Handle12963650 Occurrence Handle10.1001/archsurg.138.9.951

    Article  PubMed  Google Scholar 

  15. G Cappelli S Paladini A D'Agata (1999) ArticleTitleTumor markers in the diagnosis of pancreatic cancer Tumori 85 IssueID1 Suppl 1 S19–S21 Occurrence Handle10235075 Occurrence Handle1:STN:280:DyaK1M3ltFersQ%3D%3D

    PubMed  CAS  Google Scholar 

  16. G Civardi L Cerri L Cavanna F Fornari M Di Stasi F Binelli (1986) ArticleTitleDiagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA Tumori 72 621–4 Occurrence Handle3468674 Occurrence Handle1:STN:280:DyaL2s7itFGqsg%3D%3D

    PubMed  CAS  Google Scholar 

  17. G Del Favero C Fabris M Plebani A Panucci A Piccoli L Perobelli et al. (1986) ArticleTitleCA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis Cancer 15 IssueID57 1576–9 Occurrence Handle10.1002/1097-0142(19860415)57:8<1576::AID-CNCR2820570823>3.0.CO;2-9

    Article  Google Scholar 

  18. T Frebourg E Bercoff N Manchon J Senant JP Basuyau P Breton et al. (1988) ArticleTitleThe evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients Caner 62 2287–90 Occurrence Handle10.1002/1097-0142(19881201)62:11<2287::AID-CNCR2820621103>3.0.CO;2-H Occurrence Handle1:STN:280:DyaL1M%2FivVWitw%3D%3D

    Article  CAS  Google Scholar 

  19. J Lundin PJ Roberts P Kuusela C Haglund (1994) ArticleTitleThe prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer Br J Cancer 69 515–9 Occurrence Handle7510116 Occurrence Handle1:STN:280:DyaK2c7mvV2muw%3D%3D

    PubMed  CAS  Google Scholar 

  20. F Safi W Schlosser S Falkenreck HGC Beger (1996) ArticleTitleA 19-9 serum course and prognosis of pancreatic cancer Int. J. Pancreatol 20 155–61 Occurrence Handle9013275 Occurrence Handle1:STN:280:DyaK2s7msFGitg%3D%3D

    PubMed  CAS  Google Scholar 

  21. LH Sobin Ch Wittekind (2003) UICC TNM classification of malignant tumors EditionNumber6th ed Wiley Liss New York 3

    Google Scholar 

  22. C Catalano A Laghi F Fraioli F Pediconi A Napoli M Danti et al. (2003) ArticleTitlePancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability Eur Radiol 13 149–56 Occurrence Handle12541123 Occurrence Handle10.1007/s00330-003-0008-y

    Article  PubMed  Google Scholar 

  23. SJ Diehl KJ Lehmann M Sadick R Lachmann M Georgi (1998) ArticleTitlePancreatic cancer: value of dual-phase helical CT in assessing resectability Radiology 206 373–8 Occurrence Handle9457188 Occurrence Handle1:STN:280:DyaK1c7hvVeqsA%3D%3D

    PubMed  CAS  Google Scholar 

  24. J Durup Scheel-Hincke MB Mortensen N Qvist CP Hovendal (1999) ArticleTitleTNM staging and assessment of resectability of pancreatic cancer by laparoscopic ultrasonography Surg. Endosc 13 967–71 Occurrence Handle10526028 Occurrence Handle10.1007/s004649901148 Occurrence Handle1:STN:280:DyaK1MvlslGitg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  25. EH Tilleman OR Busch WA Bemelman TM van Gulik H Obertop DJ Gouma (2004) ArticleTitleDiagnostic laparoscopy in staging pancreatic carcinoma: developments during the past decade J. Hepatobiliary. Pancreat. Surg 11 11–6 Occurrence Handle15747029 Occurrence Handle10.1007/s00534-002-0784-9

    Article  PubMed  Google Scholar 

  26. D Delbeke CW Pinson (2004) ArticleTitlePancreatic tumors: role of imaging in the diagnosis, staging, and treatment J. Hepatobiliary. Pancreat. Surg 11 4–10 Occurrence Handle15747028 Occurrence Handle10.1007/s00534-002-0775-x

    Article  PubMed  Google Scholar 

  27. KC Conlon DS Klimstra MF Brennan (1996) ArticleTitleLong-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 223 273–9 Occurrence Handle8604907 Occurrence Handle10.1097/00000658-199603000-00007 Occurrence Handle1:STN:280:DyaK287pvFSgsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  28. MG Schlieman HS Ho RJ Bold (2003) ArticleTitleUtility of tumor markers in determining resectability of pancreatic cancer Arch. Surg 138 951–5 Occurrence Handle12963650 Occurrence Handle10.1001/archsurg.138.9.951

    Article  PubMed  Google Scholar 

  29. EM Loyer CL David RA Dubrow DB Evans C Charnsangavej (1996) ArticleTitleVascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT Abdom. Imaging 21 202–6 Occurrence Handle8661548 Occurrence Handle10.1007/s002619900046 Occurrence Handle1:STN:280:DyaK283mvFOmsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  30. GM Fuhrman C Charnsangavej JL Abbruzzese KR Cleary RG Martin CJ Fenoglio DB Evans (1994) ArticleTitleThin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms Am. J. Surg 167 104–11 Occurrence Handle7906097 Occurrence Handle10.1016/0002-9610(94)90060-4 Occurrence Handle1:STN:280:DyaK2c7ksVKqsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  31. MA Tempero E Uchida H Takasaki DA Burnett Z Steplewski PM Pour (1987) ArticleTitleRelationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer Cancer Res 47 5501–3 Occurrence Handle3308077 Occurrence Handle1:STN:280:DyaL1c%2Fgt1SgtQ%3D%3D

    PubMed  CAS  Google Scholar 

  32. M Brockhaus JL Magnani M Blaszczyk Z Steplewski H Koprowski KA Karlsson et al. (1981) ArticleTitleMonoclonal antibodies directed against the human Leb blood group antigen J. Biol. Chem 256 IssueID13 223–5

    Google Scholar 

  33. LM Tibbetts CM Doremus GN Tzanakakis MP Vezeridis (1993) ArticleTitleLiver metastases with ten human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production Cancer 71 315–21 Occurrence Handle8422623 Occurrence Handle10.1002/1097-0142(19930115)71:2<315::AID-CNCR2820710208>3.0.CO;2-B Occurrence Handle1:STN:280:DyaK3s7jslWksQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  34. EA Bakalakos WE Burak SuffixJr DC Young EW Martin SuffixJr (1999) ArticleTitleIs carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 177 2–6 Occurrence Handle10037299 Occurrence Handle10.1016/S0002-9610(98)00303-1 Occurrence Handle1:STN:280:DyaK1M7lsV2jsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  35. G Steele SuffixJr R Bleday RJ Mayer A Lindblad N Petrelli D Weaver (1991) ArticleTitleA prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Goup Protocol 6584 J Clin Oncol 9 1105–12 Occurrence Handle2045852

    PubMed  Google Scholar 

  36. EA Alsabti MH Saffo (1979) ArticleTitlePlasma levels of CEA as a prognostic marker in carcinoma of urinary bladder Urol Int 34 387–92 Occurrence Handle494440 Occurrence Handle1:STN:280:DyaL3c%2FjslCqsA%3D%3D Occurrence Handle10.1159/000280285

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan

    Shuichi Fujioka, Takeyuki Misawa, Tomoyoshi Okamoto, Takeshi Gocho, Yasuro Futagawa, Yuichi Ishida & Katsuhiko Yanaga

  2. Department of Surgery, Jikei Daisan Hospital, 4-11-1 Izumi-honcho, Komae, Tokyo, 201-8601, Japan

    Shuichi Fujioka

Authors
  1. Shuichi Fujioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeyuki Misawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoyoshi Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takeshi Gocho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasuro Futagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuichi Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katsuhiko Yanaga
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Fujioka, S., Misawa, T., Okamoto, T. et al. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 14, 539–544 (2007). https://doi.org/10.1007/s00534-006-1184-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-006-1184-3

Key words

Search

Navigation